Flatiron Health at the ISPOR Europe 2024 Annual Meeting
Flatiron Health is excited to announce its upcoming participation at the ISPOR Europe 2024 Annual Meeting, where significant research findings will be showcased. Among the highlights will be five accepted abstracts for poster presentations, as well as engaging discussions surrounding the use of real-world evidence (RWE) in healthcare decision-making.
Significant Contributions to Real-World Data
One of the core objectives of Flatiron Health is to enhance the understanding of comparative effectiveness research. According to Jonathan Kish, VP of Research Sciences at Flatiron, their participation underscores the importance of utilizing country-specific and global datasets to bolster healthcare decisions effectively. They are paving the way in employing high-quality, multi-national cancer data to assist in intricate regulatory decisions across the globe.
Event Highlights to Look Forward To
This year’s event will feature several pivotal presentations. A noteworthy poster presentation will evaluate the transportability of overall survival estimates from the US to the UK for metastatic breast cancer. This research demonstrates the validity of transporting data across borders, providing valuable insights for oncologists and healthcare policymakers.
Integration of EHR-Derived Datasets
Additionally, another poster presentation will showcase how electronic health record (EHR)-derived data can be effectively curated and combined from countries like the UK, Germany, and Japan. This work illustrates that collecting comprehensive real-world patient-level data is feasible across international borders while adhering to all local laws and regulations.
Workshop on RWE Transportability
Flatiron's Blythe Adamson will lead a workshop titled “From Data to Decisions: The Potential of RWE Transportability in Healthcare Decision Making.” The session will focus on using transportability analysis to fill the voids that often occur in high-quality real-world data across varying geographical landscapes. This information will serve as supplemental evidence in health technology assessments.
Meeting Opportunities at ISPOR Europe 2024
This is a prime opportunity for interested professionals to schedule a meeting with Flatiron Health. Attendees can learn more about the exciting research abstracts, workshops, and panels that will be presented at ISPOR Europe 2024.
Follow Flatiron Health for Updates
To keep up with the latest news and updates regarding ISPOR Europe and Flatiron Health's initiatives, be sure to follow the company on their various social media platforms.
Workshops and Discussion Leaders
The event will provide numerous workshops, including:
Exploring Advanced Methods
One such workshop will focus on advanced methods for comparing treatment sequences using real-world data, led by Nicholas Latimer from Delta Hat Ltd & University of Sheffield, alongside various experts featuring Flatiron's own Blythe Adamson.
Poster Discussions Designed for Engagement
Several poster discussions will be offered that highlight cutting-edge research. This includes a focused poster session discussing the significance of real-world data sources for oncology across major European nations, with expert contributions from Judy Tchaikovsky, Che-Rung Liu, and more.
About Flatiron Health
Flatiron Health is at the forefront of health technology, dedicated to enhancing point-of-care solutions in oncology. Leveraging AI and machine learning to harness real-world evidence, Flatiron is committed to transforming care for cancer patients, forging a modern and interconnected oncology ecosystem. Flatiron Health proudly operates as an independent affiliate of the Roche Group.
Frequently Asked Questions
What is Flatiron Health's main focus?
Flatiron Health specializes in harnessing data and technology to improve cancer care through enhanced point-of-care solutions.
What will be presented at ISPOR Europe 2024?
Flatiron Health will highlight five research abstracts focused on the transportability of real-world data and its implications for healthcare.
Who are the key speakers at the workshops?
Workshops will be led by leading experts in the field including Blythe Adamson from Flatiron and Nicholas Latimer from Delta Hat Ltd.
How does Flatiron utilize real-world data?
Flatiron uses real-world data to provide insights into cancer treatment effectiveness and to guide healthcare decision-making processes.
What is the significance of RWE transportability?
RWE transportability allows clinical insights from one region to be applicable in another, enhancing the ability to make informed healthcare decisions globally.
